Image showing pills and a magnifying glass
Safety committee meeting: November 2024 highlights

PRAC carried out its broad range of responsibilities for managing the risks associated with medicine

Read highlights
monkeypox_image_permanent_slider_1.png
Mpox regulatory workshop: Fostering collaboration to improve access to medicines

Global regulators discuss how to support medicines development and approval

Read workshop report
Handling of competing interests: revised rules for committee members and experts
Handling of competing interests: revised rules for committee members and experts

Send us your comments by 10 November 2024

Read news on policy
Seizing opportunities in a changing medicines landscape
European medicines agencies network strategy to 2028: launch of public consultation

Send us your comments by 30 November 2024

Read news on strategy
Image showing a meeting room filled with people
Management Board: highlights of October 2024 meeting

Board elects new vice chair and adopts mid-year report for 2024

Read highlights
Undated calendar on a light blue background
Improving efficiency of approval process for new medicines in the EU

How to improve quality of marketing authorisation application submissions

Read news announcement
Icon Magnify Glass

Find medicine

Find information on centrally authorised medicines
Icon Megaphone

What's new

Find all new and updated information published on our website in one place
icon speech question answer

FAQs

Find answers to the most frequent asked questions we receive

Latest news

EMA closed 1 November

The European Medicines Agency's (EMA) office is closed on Friday 1 November 2024 for All Saints’ Day.

SEE ALL NEWS

Events

Mandatory use of ISO/ICH E2B(R3) individual case safety reporting in the EU: hands-on training course using the EudraVigilance system

EudraVigilance is the EU's system for managing and analysing information on adverse reactions to medicines which have been authorised or are being studied in clinical trials in the European Economic Area (EEA) and supports the reporting and analysis of suspected adverse reactions originating from clinical trials and the post-authorisation phase of...

Online
Start date: 4 November 2024
End date: 8 November 2024
SEE ALL EVENTS
Back to top